Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Clinical factors related to recurrence after hepatic arterial concurrent chemoradiotherapy for advanced but liver-confined hepatocellular carcinoma.

Cha H, Yoon HI, Lee IJ, Koom WS, Han KH, Seong J.

J Radiat Res. 2013 Nov 1;54(6):1069-77. doi: 10.1093/jrr/rrt034. Epub 2013 Apr 30.

PMID:
23633620
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Early on-treatment predictions of clinical outcomes using alpha-fetoprotein and des-gamma-carboxy prothrombin responses in patients with advanced hepatocellular carcinoma.

Lee MH, Kim SU, Kim do Y, Ahn SH, Choi EH, Lee KH, Lee do Y, Seong J, Han KH, Chon CY, Park JY.

J Gastroenterol Hepatol. 2012 Feb;27(2):313-22. doi: 10.1111/j.1440-1746.2011.06867.x.

PMID:
21793906
[PubMed - indexed for MEDLINE]
3.

18F-fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma.

Kim BK, Kang WJ, Kim JK, Seong J, Park JY, Kim do Y, Ahn SH, Lee do Y, Lee KH, Lee JD, Han KH.

Cancer. 2011 Oct 15;117(20):4779-87. doi: 10.1002/cncr.26099. Epub 2011 Apr 5.

PMID:
21469082
[PubMed - indexed for MEDLINE]
Free Article
4.

Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis.

Park MS, Kim SU, Park JY, Kim do Y, Ahn SH, Han KH, Chon CY, Seong J.

Cancer Chemother Pharmacol. 2013 Jan;71(1):165-73. doi: 10.1007/s00280-012-1993-9. Epub 2012 Oct 19.

PMID:
23079897
[PubMed - indexed for MEDLINE]
5.

Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma.

Cheng JC, Chuang VP, Cheng SH, Huang AT, Lin YM, Cheng TI, Yang PS, You DL, Jian JJ, Tsai SY, Sung JL, Horng CF.

Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):435-42.

PMID:
10802371
[PubMed - indexed for MEDLINE]
6.

Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for advanced-stage unresectable intrahepatic cholangiocarcinoma.

Kim YI, Park JW, Kim BH, Woo SM, Kim TH, Koh YH, Lee WJ, Kim CM.

Radiat Oncol. 2013 Dec 21;8:292. doi: 10.1186/1748-717X-8-292.

PMID:
24359879
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.

Li B, Yu J, Wang L, Li C, Zhou T, Zhai L, Xing L.

Am J Clin Oncol. 2003 Aug;26(4):e92-9.

PMID:
12902905
[PubMed - indexed for MEDLINE]
8.

Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-alpha for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis.

Eun JR, Lee HJ, Moon HJ, Kim TN, Kim JW, Chang JC.

Scand J Gastroenterol. 2009;44(12):1477-86. doi: 10.3109/00365520903367262.

PMID:
19958061
[PubMed - indexed for MEDLINE]
9.

Hepatocellular carcinoma: surgical resection versus surgical resection combined with pre- and post-operative locoregional immunotherapy-chemotherapy. A prospective randomized study.

Lygidakis NJ, Pothoulakis J, Konstantinidou AE, Spanos H.

Anticancer Res. 1995 Mar-Apr;15(2):543-50.

PMID:
7539237
[PubMed - indexed for MEDLINE]
10.

Concurrent chemoradiotherapy with or without adjuvant chemotherapy in intermediate and locoregionally advanced nasopharyngeal carcinoma.

Zhang W, Dou H, Lam C, Liu J, Zhou J, Liu Y, Wang X.

Tumour Biol. 2013 Jun;34(3):1729-36. doi: 10.1007/s13277-013-0710-6. Epub 2013 Feb 23.

PMID:
23436047
[PubMed - indexed for MEDLINE]
11.

Debulking surgery followed by intraarterial 5-fluorouracil chemotherapy plus subcutaneous interferon alfa for massive hepatocellular carcinoma with multiple intrahepatic metastases: a pilot study.

Tanaka K, Yabushita Y, Nakagawa K, Kumamoto T, Matsuo K, Taguri M, Endo I.

Eur J Surg Oncol. 2013 Dec;39(12):1364-70. doi: 10.1016/j.ejso.2013.10.007. Epub 2013 Oct 23.

PMID:
24183169
[PubMed - indexed for MEDLINE]
12.

Survival of patients with advanced hepatocellular carcinoma: sorafenib versus other treatments.

Kim HY, Park JW, Nam BH, Kim HK, Choi JI, Kim TH, Kim HB, Kim CM.

J Gastroenterol Hepatol. 2011 Nov;26(11):1612-8. doi: 10.1111/j.1440-1746.2011.06751.x.

PMID:
21517968
[PubMed - indexed for MEDLINE]
13.

Unresectable hepatocellular carcinoma treated with radiotherapy and/or chemoembolization.

Chia-Hsien Cheng J, Chuang VP, Cheng SH, Lin YM, Cheng TI, Yang PS, Jian JJ, You DL, Horng CF, Huang AT.

Int J Cancer. 2001 Aug 20;96(4):243-52.

PMID:
11474499
[PubMed - indexed for MEDLINE]
14.

Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma.

Kim BK, Ahn SH, Seong JS, Park JY, Kim do Y, Kim JK, Lee do Y, Lee KH, Han KH.

Liver Int. 2011 Mar;31(3):369-76. doi: 10.1111/j.1478-3231.2010.02368.x. Epub 2010 Nov 17.

PMID:
21083802
[PubMed - indexed for MEDLINE]
15.

Pilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosis.

Han KH, Seong J, Kim JK, Ahn SH, Lee do Y, Chon CY.

Cancer. 2008 Sep 1;113(5):995-1003. doi: 10.1002/cncr.23684.

PMID:
18615601
[PubMed - indexed for MEDLINE]
Free Article
16.

Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.

Okazawa M, Mabuchi S, Isohashi F, Suzuki O, Yoshioka Y, Sasano T, Ohta Y, Kamiura S, Ogawa K, Kimura T.

Int J Gynecol Cancer. 2013 Mar;23(3):567-75. doi: 10.1097/IGC.0b013e31828703fd.

PMID:
23385284
[PubMed - indexed for MEDLINE]
17.

Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factors.

Chon YE, Seong J, Kim BK, Cha J, Kim SU, Park JY, Ahn SH, Han KH, Chon CY, Shin SK, Kim do Y.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1343-51. doi: 10.1016/j.ijrobp.2010.07.1986. Epub 2010 Oct 8.

PMID:
20934268
[PubMed - indexed for MEDLINE]
18.

Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma.

Kamiyama T, Nakanishi K, Yokoo H, Kamachi H, Tahara M, Kakisaka T, Tsuruga Y, Todo S, Taketomi A.

World J Surg Oncol. 2012 Jun 14;10:107. doi: 10.1186/1477-7819-10-107.

PMID:
22697061
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Treatment for extrahepatic metastasis of hepatocellular carcinoma following successful hepatic resection.

Aramaki M, Kawano K, Kai T, Yokoyama H, Morii Y, Sasaki A, Yoshida T, Kitano S.

Hepatogastroenterology. 1999 Sep-Oct;46(29):2931-4.

PMID:
10576375
[PubMed - indexed for MEDLINE]
20.

Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.

Yamasaki T, Kimura T, Kurokawa F, Aoyama K, Ishikawa T, Tajima K, Yokoyama Y, Takami T, Omori K, Kawaguchi K, Tsuchiya M, Terai S, Sakaida I, Okita K.

J Gastroenterol. 2005 Jan;40(1):70-8.

PMID:
15692792
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk